Skip to main content

Recurrence of Hepatocellular Carcinoma after Living Donor Liver Transplantation: What is the Current Optimal Approach to Prevent Recurrence?

World Journal of Surgery volume 35, pages 1355–1359 (2011)Cite this article

Abstract

Background

Liver transplantation plays an important role in the multimodal treatment options for patients with hepatocellular carcinoma (HCC). However, there has been little information about the prognosis for HCC recurrence after living donor liver transplantation (LDLT).

Methods

We retrospectively analyzed 164 HCC patients who underwent LDLT at our institution between February 1999 and March 2009.

Results

In all, 23 of 164 liver recipients developed HCC recurrence 1 to 44 months (median 8 months) after LDLT. The 5-year survival was significantly lower for patients with recurrence than for patients without recurrence (14 vs. 82%; p < 0.0001). The 3-year survival was significantly lower for patients with early recurrence (≤ 1 year) than for patients with late recurrence (>1 year) (8 vs. 40%; p = 0.0082). Concerning sites of first tumor recurrence, the 3-year survival rate in patients with recurrence in the graft liver was significantly higher than that of patients with recurrence to other organs (50 vs. 17%, respectively; p = 0.0421).

Conclusions

As the prognosis of patients with HCC recurrence is quite poor, currently the optimal method of preventing HCC recurrence would be the use of appropriate criteria to select candidates for LDLT.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699

    PubMed  Article  CAS  Google Scholar 

  2. Takada Y, Ito T, Ueda M et al (2007) Living donor liver transplantation for patients with HCC exceeding Milan criteria: a proposal of expanded criteria. Dig Dis 25:299–302

    PubMed  Article  Google Scholar 

  3. Soejima Y, Taketomi A, Yoshizumi T et al (2007) Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 83:893–899

    PubMed  Article  Google Scholar 

  4. Toso C, Asthana S, Bigam DL et al (2009) Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database. Hepatology 49:832–838

    PubMed  Article  Google Scholar 

  5. Morioka D, Egawa H, Kasahara M et al (2007) Outcomes of adult-to-adult living donor liver transplantation: a single institution’s experience with 335 consecutive cases. Ann Surg 245:315–325

    PubMed  Article  Google Scholar 

  6. Inomata Y, Uemoto S, Asonuma K et al (2000) Right lobe graft in living donor liver transplantation. Transplantation 69:258–264

    PubMed  Article  CAS  Google Scholar 

  7. Ito T, Kiuchi T, Egawa H et al (2003) Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation 76:158–163

    PubMed  Article  Google Scholar 

  8. Inomata Y, Tanaka K, Egawa H et al (1996) The evolution of immunosuppression with FK 506 in pediatric living related liver transplantation. Transplantation 61:247–252

    PubMed  Article  CAS  Google Scholar 

  9. Takada Y, Ueda M, Ito T et al (2006) Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl 12:912–919

    PubMed  Article  Google Scholar 

  10. Roayaie S, Schwartz JD, Sung MW et al (2004) Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 10:534–540

    PubMed  Article  Google Scholar 

  11. Fisher RA, Kulik LM, Freise CE et al (2007) Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 7:1601–1608

    PubMed  Article  CAS  Google Scholar 

  12. Lo CM, Fan ST, Liu CL et al (2007) Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 94:78–86

    PubMed  Article  CAS  Google Scholar 

  13. Lo CM, Fan ST, Liu CL et al (2004) The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 10:440–447

    PubMed  Article  Google Scholar 

  14. Todo S, Furukawa H, Tada M (2007) Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 13:S48–S54

    PubMed  Article  Google Scholar 

  15. Yeganeh M, Finn RS, Saab S (2009) Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib. Am J Transplant 9:2851–2854

    PubMed  Article  CAS  Google Scholar 

  16. Yao FY, Xiao L, Bass NM et al (2007) Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 7:2587–2596

    PubMed  Article  CAS  Google Scholar 

  17. Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43

    PubMed  Article  Google Scholar 

Download references

Conflicts of interest

The authors declare no potential conflicts of interest.

Author information

Affiliations

  1. Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Toshimi Kaido, Akira Mori, Yasuhiro Ogura, Koichiro Hata, Atsushi Yoshizawa, Taku Iida & Shinji Uemoto

Authors
  1. Toshimi Kaido
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akira Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuhiro Ogura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Koichiro Hata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Atsushi Yoshizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Taku Iida
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shinji Uemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toshimi Kaido.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kaido, T., Mori, A., Ogura, Y. et al. Recurrence of Hepatocellular Carcinoma after Living Donor Liver Transplantation: What is the Current Optimal Approach to Prevent Recurrence?. World J Surg 35, 1355–1359 (2011). https://doi.org/10.1007/s00268-011-1045-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-011-1045-3

Keywords

  • Sorafenib
  • Tace
  • Live Donor Liver Transplantation
  • Graft Liver
  • Milan Criterion